Skip to Content

335 (Pyridostigmine bromide extended-release 180 mg)

Pill imprint 335 has been identified as Pyridostigmine bromide extended-release 180 mg.

Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pyridostigmine bromide extended-release
Imprint:
335
Strength:
180 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinergic muscle stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Alvogen, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide